METASTATIC OVARIAN CANCER
Clinical trials for METASTATIC OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC OVARIAN CANCER trials appear
Sign up with your email to follow new studies for METASTATIC OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental antibody combo shows promise against tough cancers
Disease control TerminatedThis study tested a new antibody called ICT01 combined with low-dose interleukin-2 (IL-2) in 56 people with advanced solid tumors like colorectal, ovarian, and pancreatic cancer. The goal was to see if the combo is safe and can shrink tumors. Early results suggest it may help con…
Matched conditions: METASTATIC OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: ImCheck Therapeutics, an Ipsen company • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Pazopanib dose hunt in frail seniors halted early
Disease control TerminatedThis phase 1 study tested the cancer drug pazopanib in 18 frail elderly patients (aged 75+) with metastatic cancers like kidney, lung, or breast cancer. The goal was to find the highest safe dose by starting at 400 mg daily and increasing if tolerated. The study was terminated ea…
Matched conditions: METASTATIC OVARIAN CANCER
Phase: PHASE1 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC